Imaging Tau in Alzheimer's Disease and Normal Aging
Imaging Tau in Alzheimer's Disease and Normal Aging With 18F-MK-6240
Sponsor: National Institute on Aging (NIA)
Listed as NCT03373604, this PHASE2 trial focuses on Alzheimer Disease and remains completed. Sponsored by National Institute on Aging (NIA), it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Jun 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Jun 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Sep 2021 — Sep 2022 [monthly]
Recruiting PHASE2
Status: Enrolling By Invitation → Recruiting
▶ Show 7 earlier versions
-
Jan 2021 — Sep 2021 [monthly]
Enrolling By Invitation PHASE2
-
Sep 2019 — Jan 2021 [monthly]
Enrolling By Invitation PHASE2
-
Aug 2018 — Sep 2019 [monthly]
Enrolling By Invitation PHASE2
-
Jul 2018 — Aug 2018 [monthly]
Enrolling By Invitation PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Enrolling By Invitation PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Enrolling By Invitation PHASE2
Status: Recruiting → Enrolling By Invitation
-
Dec 2017 — Jan 2018 [monthly]
Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute on Aging (NIA)
- Patrick Lao
For direct contact, visit the study record on ClinicalTrials.gov .